Outlook Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-54.3M | $-54.3M | — | $4.9M |
| FY2022 | $-56.7M | $-56.7M | — | $7.7M |
| FY2023 | $-43.0M | $-43.0M | — | $5.5M |
| FY2024 | $-68.8M | $-68.8M | — | $5.4M |
| FY2025 | $-51.8M | $-51.8M | — | $8.9M |